Cetera Investment Advisers’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Buy
+10,470
New +$305K ﹤0.01% 3987
2024
Q2
Sell
-160,509
Closed -$3.85M 3830
2024
Q1
$3.85M Buy
+160,509
New +$3.59M 0.01% 1120

Other funds holding REVS

Cetera Investment Advisers's REVS Position: Q1 2026 in Review

Cetera Investment Advisers opened a new position in Columbia Research Enhanced Value ETF (REVS) in Q1 2026: 10,470 shares worth $300K. The stake represents ﹤0.01% of the portfolio and ranks #3987 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in REVS as recently as Q1 2024.

Cetera Investment Advisers first reported a position in REVS in Q1 2024 and has held it in 2 quarters since. The position peaked at $3.85M in Q1 2024. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.

  • Cetera Investment Advisers held 10,470 shares of Columbia Research Enhanced Value ETF worth $300K as of Q1 2026.
  • Columbia Research Enhanced Value ETF was a new Cetera Investment Advisers position in Q1 2026.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3987 holding.
  • Cetera Investment Advisers first reported a position in Columbia Research Enhanced Value ETF in Q1 2024 and has held it in 2 quarters since.
  • Cetera Investment Advisers's Columbia Research Enhanced Value ETF position peaked at $3.85M in Q1 2024.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.